- Home
- ABX vs OFIX Comparison
ABX vs OFIX Comparison
Compare ABX & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABX | OFIX |
|---|---|---|
| Founded | 2004 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 725.3M | 500.2M |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | ABX | OFIX |
|---|---|---|
| Price | $10.09 | $12.02 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $11.00 | ★ $17.25 |
| AVG Volume (30 Days) | ★ 614.0K | 269.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.02% | N/A |
| EPS Growth | N/A | ★ 29.39 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $822,312,000.00 |
| Revenue This Year | $6.73 | $6.32 |
| Revenue Next Year | $13.52 | $6.01 |
| P/E Ratio | $74.88 | ★ N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $7.18 | $10.25 |
| 52 Week High | $10.54 | $17.00 |
Technical Indicators
Market Signals| Indicator | ABX | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 65.30 | 34.73 |
| Support Level | $8.10 | $10.55 |
| Resistance Level | $10.50 | $16.38 |
| Average True Range (ATR) | 0.47 | 0.48 |
| MACD | 0.02 | -0.08 |
| Stochastic Oscillator | 77.81 | 13.39 |
Price Performance
Historical ComparisonAbout ABX Abacus Global Management Inc. Class A Common Stock
Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The Company organizes its business into five reportable segments Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. Its operations are confined to the United States.
About OFIX Orthofix Medical Inc. (DE)
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.